CLYM
Price
$4.07
Change
+$0.30 (+7.96%)
Updated
Jan 16, 11:16 AM (EDT)
Capitalization
257.06M
52 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$3.16
Change
-$0.35 (-9.97%)
Updated
Jan 15 closing price
Capitalization
228.31M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLYM vs ZNTL

Header iconCLYM vs ZNTL Comparison
Open Charts CLYM vs ZNTLBanner chart's image
Climb Bio
Price$4.07
Change+$0.30 (+7.96%)
Volume$650
Capitalization257.06M
Zentalis Pharmaceuticals
Price$3.16
Change-$0.35 (-9.97%)
Volume$1.39M
Capitalization228.31M
CLYM vs ZNTL Comparison Chart in %
CLYM
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CLYM vs. ZNTL commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (CLYM: $3.77 vs. ZNTL: $3.16)
Brand notoriety: CLYM and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 42% vs. ZNTL: 91%
Market capitalization -- CLYM: $257.06M vs. ZNTL: $228.31M
CLYM [@Biotechnology] is valued at $257.06M. ZNTL’s [@Biotechnology] market capitalization is $228.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 1 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • CLYM’s FA Score: 1 green, 4 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLYM and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 5 TA indicator(s) are bullish while ZNTL’s TA Score has 7 bullish TA indicator(s).

  • CLYM’s TA Score: 5 bullish, 5 bearish.
  • ZNTL’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than CLYM.

Price Growth

CLYM (@Biotechnology) experienced а -17.69% price change this week, while ZNTL (@Biotechnology) price change was +11.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +41.99%.

Reported Earning Dates

CLYM is expected to report earnings on Mar 09, 2026.

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYM($257M) has a higher market cap than ZNTL($228M). ZNTL YTD gains are higher at: 134.074 vs. CLYM (-5.750). CLYM has higher annual earnings (EBITDA): -59.5M vs. ZNTL (-152.83M). ZNTL has more cash in the bank: 281M vs. CLYM (86.9M). CLYM has less debt than ZNTL: CLYM (580K) vs ZNTL (36.7M). ZNTL has higher revenues than CLYM: ZNTL (26.9M) vs CLYM (0).
CLYMZNTLCLYM / ZNTL
Capitalization257M228M113%
EBITDA-59.5M-152.83M39%
Gain YTD-5.750134.074-4%
P/E RatioN/AN/A-
Revenue026.9M-
Total Cash86.9M281M31%
Total Debt580K36.7M2%
TECHNICAL ANALYSIS
Technical Analysis
CLYMZNTL
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
77%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CLYM
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USAQ0.770.02
+2.27%
QHSLab Inc
FKKFY16.95N/A
N/A
Fukuoka Financial Group, Inc.
AVHHL0.71N/A
N/A
Avita Medical, Inc.
OSGCF13.66N/A
N/A
Osg Corp. Co. Ltd.
KSHTY1.98-0.14
-6.60%
KUAISHOU TECHNOLOGY

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with KYTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
-4.80%
KYTX - CLYM
42%
Loosely correlated
-4.80%
IMVT - CLYM
37%
Loosely correlated
-4.94%
RGNX - CLYM
34%
Loosely correlated
-7.96%
ZNTL - CLYM
34%
Loosely correlated
-9.97%
VYGR - CLYM
33%
Poorly correlated
-7.51%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with RVMD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
-9.97%
RVMD - ZNTL
47%
Loosely correlated
+1.69%
ERAS - ZNTL
47%
Loosely correlated
+15.04%
CGON - ZNTL
44%
Loosely correlated
-4.40%
IPSC - ZNTL
43%
Loosely correlated
+13.86%
ELVN - ZNTL
41%
Loosely correlated
-3.38%
More